Pharmacokinetics and urinary excretion of sulphadimidine in buffalo calves

J Vet Med A Physiol Pathol Clin Med. 2000 Oct;47(8):501-5. doi: 10.1046/j.1439-0442.2000.00311.x.

Abstract

Pharmacokinetics and urinary excretion of sulphadimidine (SDI) were determined in buffalo calves following single oral administration (150 mg/kg). The plasma levels of free sulphadimidine were above minimum effective therapeutic concentration (> 40 micrograms/ml) between 4 and 12 h and the N4-acetylated form of the drug was in the range of 7.2-19.3%. Kinetic evaluation of plasma levels was performed using a two-compartment open model. The absorption and elimination half-lives of SDI were 3.01 and 11.94 h, respectively. Based on this study, an optimal dosage regimen of sulphadimidine in buffalo calves would be 100 mg/kg, followed by 50 mg/kg at 12 h intervals. Sulphadimidine was mainly excreted in the urine as free amine. The percentage of N4-acetyl sulphadimidine in urine was comparatively higher than in plasma.

MeSH terms

  • Animals
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / blood
  • Anti-Infective Agents / pharmacokinetics*
  • Anti-Infective Agents / urine
  • Area Under Curve
  • Buffaloes / physiology*
  • Half-Life
  • Male
  • Sulfamethazine / administration & dosage
  • Sulfamethazine / blood
  • Sulfamethazine / pharmacokinetics*
  • Sulfamethazine / urine

Substances

  • Anti-Infective Agents
  • Sulfamethazine